Potentially self-reactive B cells constitute a large portion of the peripheral B cell repertoire in both mice and humans. Maintenance of autoreactive B cell populations could conceivably be detrimental to the host but their conservation throughout evolution suggests performance of a critical and beneficial immune function. We discuss herein how the process of clonal redemption may provide insight to preservation of an autoreactive B cell pool in the context of infection and autoimmunity. Clonal redemption refers to additional recombination or hypermutation events decreasing affinity for self-antigen, while increasing affinity for foreign antigens. We then review findings in murine models and human patients to consider whether clonal redemption may be able to provide tumor antigen-specific B cells and how this may or may not predispose patients to autoimmunity.
CITATION STYLE
McCaw, T. R., Lofftus, S. Y., & Crompton, J. G. (2023). Clonal redemption of B cells in cancer. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1277597
Mendeley helps you to discover research relevant for your work.